Renal cell carcinoma (RCC) epidemiology and genetic variation, risk factor-based primary and secondary prevention with early detection with a focus on biomarkers
Received Date: Aug 01, 2022 / Accepted Date: Aug 27, 2022 / Published Date: Aug 29, 2022
Abstract
Renal cell carcinoma (RCC), with 400,000 diagnoses and 180,000 deaths in 2020, represents 2.4% of all cancer diagnoses globally industrialised nations with the greatest rates of sickness, particularly in Europe and North America.As more nations adopt Western lifestyles, incidence is expected to rise in the future. In addition to intervening variables like smoking, obesity, hypertension, diabetes, nutrition, and alcohol, RCC risk factors also include fixed characteristics like gender, age, and inherited disorders. The development of early diagnostic techniques, knowledge of prenatal risk factors, and intervening measures in primary prevention are crucial for RCC. The epidemiology of RCC, risk factors,and biomarkers implicated in lowering incidence and enhancing survival will all be covered in this review.
Keywords: Renal cell carcinoma; Epidemiology; Prevention; Genetic illness
Citation: Harker JA (2022) Renal Cell Carcinoma (RCC) Epidemiology and Genetic Variation, Risk Factor-Based Primary and Secondary Prevention with Early Detection with a Focus on Biomarkers. Int J Inflam Cancer Integr Ther, 9: 195. Doi: 10.4172/2381-8727.1000195
Copyright: © 2022 Harker JA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 626
- [From(publication date): 0-2022 - Aug 31, 2024]
- Breakdown by view type
- HTML page views: 472
- PDF downloads: 154
